<DOC>
	<DOCNO>NCT01251900</DOCNO>
	<brief_summary>Background : - BRCA1 BRCA2 gene mutation link high risk develop breast cancer cancer , may associate type breast cancer difficult treat likely recur . New cancer treatment develop specifically treat individual gene mutation . However , information need prevalence mutation minority population , include Hispanic/Latino population . To study population , researcher interest collect genetic material ( DNA ) medical history information Hispanic/Latino woman diagnose breast cancer . Objectives : - To collect saliva sample medical family history information Hispanic/Latino woman breast cancer . Eligibility : - Hispanic/Latino woman least 18 year age diagnose breast cancer . Design : - Participants complete questionnaire information place birth , languages speak parent grandparent , information breast cancer diagnosis . - Participants provide saliva sample ( 2 3 tablespoon ) analysis . - No treatment provide part protocol .</brief_summary>
	<brief_title>BRCA Mutations Latinas</brief_title>
	<detailed_description>BACKGROUND : - Mutations BRCA1 BRCA2 gene predispose breast ovarian cancer , increasingly recognize prostate pancreatic cancer . - Basal/ Triple negative breast cancer associate BRCA mutation ethnicities.However link BRCA gene mutation Basil/ triple negative disease Hispanic/ Latino woman know . - Common recurrent mutation BRCA1 BRCA2 exist Hispanic/ Latino community . - New therapy PARP inhibitor may particularly effective BRCA mutation carrier . - Therefore unique opportunity exist identify woman underserved minority may eligible benefit new target therapy . OBJECTIVES : - The primary objective collect saliva sample histology data 2000 Hispanic/ Latino subject breast cancer source DNA , analyze BRCA1 BRCA2 genes.. ELIGIBILITY : - All Hispanics female , age 18 , breast cancer eligible . DESIGN : - Natural history study 2000 Hispanic/Latino woman breast cancer , 1000 triple negative disease , 1000 without . - Obtain clinical pathology report relevant history data subject . - Analyze recurrent BRCA1 BRCA2 mutation</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA : Patient must selfidentified Hispanic/Latino origin . Patients must histologically cytologically confirm diagnosis breast cancer . Age great equal 18 year . Ability understand willingness sign write informed consent document . Must willing able provide saliva sample , answer questionnaire data online complete paper questionnaire , request copy pathology report . EXCLUSION CRITERIA : Males subject age 18 .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 24, 2017</verification_date>
	<keyword>Triple Negative Disease</keyword>
	<keyword>BRCA1</keyword>
	<keyword>BRCA2</keyword>
	<keyword>Hispanic/Latino</keyword>
	<keyword>Breast Cancer</keyword>
</DOC>